NCR Atleos Corp. (NATL) will replace iTeos Therapeutics (ITOS) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, October 18. S&P MidCap 400 constituent NCR Corp. (NCR) is spinning off NCR Atleos in a transaction expected to be completed on October 17. Following the spin-off, the NCR parent will have a name and symbol change to NCR Voyix Corp. (VYX) and will remain in the S&P MidCap 400. iTeos Therapeutics is no longer representative of the small-cap market space.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ITOS:
- National Interstate to replace iTeos in S&P 600 at open on 10/18
- iTeos to Participate in Upcoming Investor Conferences
- iTeos should be up ‘sharply’ on Roche data, says Piper Sandler
- iTeos jumps after Roche inadvertently publishes positive TIGIT data
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue